Contact us

ESH Video

#ESHAL2024 REMINDER: ABSTRACT & CLINICAL CASE SUBMISSION ARE OPEN!

ESH 4^th How to Diagnose and Treat

ACUTE LEUKAEMIAS

Save the date: March 1-3, 2024

Stockholm, Sweden
#ESHAL2024

REMINDER: ABSTRACT & CLINICAL CASE SUBMISSION IS OPEN!

Deadline: December 14^th, 2023

REGISTRATION IS ALSO OPEN!

Join us in Stockholm next year!

About the Conference:

ESH How to Diagnose and Treat meetings are disease-specific meetings that address up to date diagnostic and clinical management which is greatly facilitated by and discussion of real clinical cases. Intensive interaction between the speakers and participants will be helpful in spreading knowledge.

Novel and still evolving insights into the biology and diagnosis of acute myeloid leukaemias (AMLs) and acute lymphoblastic leukaemias (ALL), has resulted in new drug approvals and new therapeutic options to treat newly-diagnosed as well as relapsed/refractory disease. Recently updates on prognostication and classification of acute leukemias have been published which will be discussed in various sessions

The programme of this “How to Diagnose and Treat: Acute Leukaemias” includes genomic analysis and cutting-edge technics in routine diagnosis, targeted therapies and standard of care treatments allogeneic haematopoietic stem cell (HSCT) transplantation and innovative immunotherapies, as well as diagnosis and management of rare acute leukaemia subtypes. Clonal hematopoiesis will be covered in detail. Novel trial designs instrumental for smarter drug development is discussed in a separate session.

For more information, click here!